Chemotherapy costs associated with receipt of the adoption of oncotype DX in early-stage breast cancer within the SEER-Medicare population. This is an ASCO Meeting Abstract from the 2016 Quality Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results